SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Todd A Kerensky, Alice B Gottlieb, Shimrat Yaniv, Shiu-chung Au, Etanercept : efficacy and safety for approved indications, Expert Opinion on Drug Safety, 2012, 11, 1, 121

    CrossRef

  2. 2
    Mohd Shahrir Mohamed Said, Sazliyana Shaharir, Sakthiswary Rajalingham, Sheikh Abdullah, Aizan bin Hassanudin, Ngiu Soon, Mohd Shahid, Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report, Journal of Medical Case Reports, 2012, 6, 1, 10

    CrossRef

  3. 3
    Carlos Pineda, Walter P. Maksymowych, Imaging and Clinical Measurements, The American Journal of the Medical Sciences, 2012, 343, 5, 345

    CrossRef

  4. 4
    S. M. M. Verstappen, B. Fautrel, S. Dadoun, D. P. M. Symmons, A. Boonen, Methodological issues when measuring paid productivity loss in patients with arthritis using biologic therapies: an overview of the literature, Rheumatology, 2012, 51, 2, 216

    CrossRef

  5. 5
    Aamir Saeed, Ankylosing spondylitis in Ireland: patient access and response to TNF-α blockers, Rheumatology International, 2011, 32, 5, 1305

    CrossRef

  6. 6
    Juergen Braun, Irene E. van der Horst-Bruinsma, Feng Huang, Ruben Burgos-Vargas, Bonnie Vlahos, Andrew S. Koenig, Bruce Freundlich, Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double-blind trial, Arthritis & Rheumatism, 2011, 63, 6
  7. 7
    Xavier Juanola Roura, Pedro Zarco Montejo, Jesús Sanz Sanz, Santiago Muñoz Fernández, Juan Mulero Mendoza, Luis Francisco Linares Ferrando, Jordi Gratacós Masmitja, Rosario García de Vicuña, Cristina Fernandez Carballido, Eduardo Collantes Estevez, Enrique Batlle Gualda, Rafael Ariza Ariza, Estíbaliz Loza Santamaría, Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in Spondyloarthritis except for Psoriatic Arthritis, Reumatología Clínica (English Edition), 2011, 7, 2, 113

    CrossRef

  8. 8
    Xavier Juanola Roura, Pedro Zarco Montejo, Jesús Sanz Sanz, Santiago Muñoz Fernández, Juan Mulero Mendoza, Luis Francisco Linares Ferrando, Jordi Gratacós Masmitja, Rosario García de Vicuña, Cristina Fernandez Carballido, Eduardo Collantes Estevez, Enrique Batlle Gualda, Rafael Ariza Ariza, Estíbaliz Loza Santamaría, Documento SER de consenso sobre el uso de terapias biológicas en la espondilitis anquilosante y otras espondiloartritis, excepto la artritis psoriásica, Reumatología Clínica, 2011, 7, 2, 113

    CrossRef

  9. 9
    Isabelle Chary-Valckenaere, Maria-Antonietta d’Agostino, Damien Loeuille, Place de l’imagerie dans la spondylarthrite, Revue du Rhumatisme, 2011, 78, 1, 26

    CrossRef

  10. 10
    Isabelle Chary-Valckenaere, Maria-Antonietta d’Agostino, Damien Loeuille, Role for imaging studies in ankylosing spondylitis, Joint Bone Spine, 2011, 78, 2, 138

    CrossRef

  11. 11
    Xenofon Baraliakos, Juergen Braun, Spondyloarthritides, Best Practice & Research Clinical Rheumatology, 2011, 25, 6, 825

    CrossRef

  12. 12
    Ferhan A. Asghar, Gregory P. Graziano, Charles Kuntz, Youmans Neurological Surgery, 2011,

    CrossRef

  13. 13
    Joachim Sieper, Rheumatology, 2011,

    CrossRef

  14. 14
    Xenofon Baraliakos, Juergen Braun, Anti-TNF-α therapy with infliximab in spondyloarthritides, Expert Review of Clinical Immunology, 2010, 6, 1, 9

    CrossRef

  15. 15
    Chung-Tei Chou, Chang-Youh Tsai, Tung-Hua Liang, Te-Ming Chang, Chen-Hung Lai, Cheng-Chung Wei, Kun-Hung Chen, Shih-Chang Lin, Chia-Li Yu, Lieh-Bang Liou, Shue-Fen Luo, Chyou-Shen Lee, Yin-Tzu Hsue, Chung-Ming Huang, Jiunn-Hong Chen, Ning-Sheng Lai, He-Hsiung Cheng, Tien-Tsai Cheng, Han-Ming Lai, Wen-Chan Tsai, Jeng-Hsien Yen, Ling-Ying Lu, Chung-Pei Chang, Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis, Modern Rheumatology, 2010, 20, 6, 580

    CrossRef

  16. 16
    Gino A. Vena, Michelangelo Vestita, Nicoletta Cassano, Can early treatment with biologicals modify the natural history of comorbidities?, Dermatologic Therapy, 2010, 23, 2
  17. 17
    Huseyin TE Ozer, Zeynep Ozbalkan, Clinical efficacy of TNF-α inhibitors: an update, International Journal of Clinical Rheumatology, 2010, 5, 1, 101

    CrossRef

  18. 18
    Mikkel Østergaard, René Panduro Poggenborg, Mette Bjørndal Axelsen, Susanne Juhl Pedersen, Magnetic resonance imaging in spondyloarthritis – how to quantify findings and measure response, Best Practice & Research Clinical Rheumatology, 2010, 24, 5, 637

    CrossRef

  19. 19
    Sinead Brophy, Mike B Gravenor, Stefan Siebert, Major flares as a diagnostic and prognostic measure when assessing ankylosing spondylitis severity, International Journal of Clinical Rheumatology, 2010, 5, 4, 399

    CrossRef

  20. 20
    K.B. Madsen, A.G. Jurik, MRI grading method for active and chronic spinal changes in spondyloarthritis, Clinical Radiology, 2010, 65, 1, 6

    CrossRef

  21. 21
    Nigil Haroon, MRI in ankylosing spondylitis: To be or not to be, Indian Journal of Rheumatology, 2010, 5, 4, 185

    CrossRef

  22. 22
    S. M. M. Verstappen, K. D. Watson, M. Lunt, K. McGrother, D. P. M. Symmons, K. L. Hyrich, Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology, 2010, 49, 8, 1570

    CrossRef

  23. 23
    Matthew P. Bunyard, Current Clinical Medicine, 2010,

    CrossRef

  24. 24
    L. Goh, A. Samanta, A systematic medline analysis of therapeutic approaches in ankylosing spondylitis, Rheumatology International, 2009, 29, 10, 1123

    CrossRef

  25. 25
    Sabine Weckbach, Whole-body MR imaging for patients with rheumatism, European Journal of Radiology, 2009, 70, 3, 431

    CrossRef

  26. 26
    Ruxandra Elena Schiotis, Alejandro Escudero-Contreras, Janitzia Vazquez-Mellado, Eduardo Collantes-Estévez, Ankylosing spondylitis and other spondyloarthropathies: extra-articular manifestations and their management, Future Rheumatology, 2008, 3, 5, 457

    CrossRef

  27. 27
    Jane Zochling, Assessment and treatment of ankylosing spondylitis: current status and future directions, Current Opinion in Rheumatology, 2008, 20, 4, 398

    CrossRef

  28. 28
    Jane Zochling, Assessment and treatment of ankylosing spondylitis: current status and future directions, Current Opinion in Internal Medicine, 2008, 7, 5, 520

    CrossRef

  29. 29
    Yong-Geun Jeong, Sang-Yong Lee, Hyun-Ok Kim, Soo-Kyoung Kim, Jae-Hee Kim, Wan Hee Yoo, Sang-Il Lee, Assessment of Clinical Effect and Changes of Sacroiliac Joint by CT and MRI in Patients with Ankylosing Spondylitis during Therapy with Etanercept, The Journal of the Korean Rheumatism Association, 2008, 15, 1, 39

    CrossRef

  30. 30
    Jose Maria Pego-Reigosa, David A. Isenberg, Autoimmune diseases, Medicine, 2008, 36, 5, 279

    CrossRef

  31. 31
    Hans-Eckhard Langer, Biologicals in der frühen Behandlung des M. Bechterew und verwandter Spondyloarthritiden, Wiener Medizinische Wochenschrift, 2008, 158, 7-8, 200

    CrossRef

  32. 32
    Matthew L. Mundwiler, Khawar Siddique, Jeffrey M. Dym, Brian Perri, J. Patrick Johnson, Michael H. Weisman, Complications of the spine in ankylosing spondylitis with a focus on deformity correction, Neurosurgical FOCUS, 2008, 24, 1, E6

    CrossRef

  33. 33
    Joachim Sieper, Heiner Appel, Jürgen Braun, Martin Rudwaleit, Critical appraisal of assessment of structural damage in ankylosing spondylitis: Implications for treatment outcomes, Arthritis & Rheumatism, 2008, 58, 3
  34. 34
    Raquel Almodóvar González, Jorge Juan Prada, Pedro Zarco Montejo, Francisco Javier Quirós Donate, Ramón Mazzucchelli Esteban, Dorso-Lumbar Pain in a Woman Diagnosed With Ankylosing Spondylitis, Reumatología Clínica (English Edition), 2008, 4, 2, 67

    CrossRef

  35. 35
    Ulrich Weber, Walter P. Maksymowych, How does imaging help the clinician in the evaluation and management of spondyloarthritis?, Skeletal Radiology, 2008, 37, 6, 487

    CrossRef

  36. 36
    Raquel Almodóvar González, Jorge Juan Prada, Pedro Zarco Montejo, Francisco Javier Quirós Donate, Ramón Mazzucchelli Esteban, Mujer diagnosticada de espondilitis anquilosante con dolor dorsolumbar, Reumatología Clínica, 2008, 4, 2, 67

    CrossRef

  37. 37
    Désirée van der Heijde, Robert Landewé, Xenofon Baraliakos, Harry Houben, Astrid van Tubergen, Paul Williamson, Weichun Xu, Daniel Baker, Neil Goldstein, Jürgen Braun, Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis, Arthritis & Rheumatism, 2008, 58, 10
  38. 38
    R. N. Jois, A. J. Macgregor, K. Gaffney, Recognition of inflammatory back pain and ankylosing spondylitis in primary care, Rheumatology, 2008, 47, 9, 1364

    CrossRef

  39. 39
    Chan-Bum Choi, Tae-Jong Kim, Hee-Jin Park, Wan-Sik Uhm, Jae-Bum Jun, Sang-Cheol Bae, Dae-Hyun Yoo, Tae-Hwan Kim, Safety and Clinical Responses in Ankylosing Spondylitis after Three Months of Etanercept Therapy, Journal of Korean Medical Science, 2008, 23, 5, 852

    CrossRef

  40. 40
    Hernan Castro-Rueda, Arthur Kavanaugh, The treatment of psoriatic arthritis and inflammatory spondylitis, Current Pain and Headache Reports, 2008, 12, 6, 412

    CrossRef

  41. 41
    Tue Secher Jensen, Jaro Karppinen, Joan S. Sorensen, Jaakko Niinimäki, Charlotte Leboeuf-Yde, Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain, European Spine Journal, 2008, 17, 11, 1407

    CrossRef

  42. 42
    J. Braun, J. Sieper, What is the most important outcome parameter in ankylosing spondylitis?, Rheumatology, 2008, 47, 12, 1738

    CrossRef

  43. 43
    Joachim Sieper, Martin Rudwaleit, Jürgen Braun, Adalimumab for the treatment of ankylosing spondylitis, Expert Opinion on Pharmacotherapy, 2007, 8, 6, 831

    CrossRef

  44. 44
    Robert G. W. Lambert, David Salonen, Proton Rahman, Robert D. Inman, Robert L. Wong, Steven G. Einstein, Glen T. D. Thomson, Andre Beaulieu, Denis Choquette, Walter P. Maksymowych, Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double-blind, placebo-controlled study, Arthritis & Rheumatism, 2007, 56, 12
  45. 45
    Pascale Schwab, Atul Deodhar, Adalimumab: effective TNF-blockade therapy for ankylosing spondylitis, Future Rheumatology, 2007, 2, 5, 455

    CrossRef

  46. 46
    Ulrich Weber, Rudolf O. Kissling, Juerg Hodler, Advances in musculoskeletal imaging and their clinical utility in the early diagnosis of spondyloarthritis, Current Rheumatology Reports, 2007, 9, 5, 353

    CrossRef

  47. 47
    Yasser Ragab, Yasser Emad, Alaa Abou-Zeid, Bone marrow edema syndromes of the hip: MRI features in different hip disorders, Clinical Rheumatology, 2007, 27, 4, 475

    CrossRef

  48. 48
    J. Braun, X. Baraliakos, J. Listing, J. Davis, D. van der Heijde, H. Haibel, M. Rudwaleit, J. Sieper, Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents, Arthritis Care & Research, 2007, 57, 4
  49. 49
    L. Goh, P. Suresh, A. Gafoor, P. Hughes, P. Hickling, Disease activity in longstanding ankylosing spondylitis—a correlation of clinical and magnetic resonance imaging findings, Clinical Rheumatology, 2007, 27, 4, 449

    CrossRef

  50. 50
    Sheridan M Hoy, Lesley J Scott, Etanercept, Drugs, 2007, 67, 17, 2609

    CrossRef

  51. 51
    Rik J. U. Lories, Inge Derese, Cosimo de Bari, Frank P. Luyten, Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis, Arthritis & Rheumatism, 2007, 56, 2
  52. 52
    Jane Zochling, Xenofon Baraliakos, Kay-Geert Hermann, J??rgen Braun, Magnetic resonance imaging in ankylosing spondylitis, Current Opinion in Rheumatology, 2007, 19, 4, 346

    CrossRef

  53. 53
    Augustine M Manadan, Neena James, Joel A Block, New therapeutic approaches for spondyloarthritis, Current Opinion in Rheumatology, 2007, 19, 3, 259

    CrossRef

  54. 54
    Tanja Spoettl, Martin Hausmann, Frank Klebl, Andrea Dirmeier, Bodo Klump, Joerg Hoffmann, Hans Herfarth, Antje Timmer, Gerhard Rogler, Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients, Inflammatory Bowel Diseases, 2007, 13, 6
  55. 55
    Walter P. Maksymowych, Suhkvinder S. Dhillon, Roy Park, David Salonen, Robert D. Inman, Robert G. W. Lambert, Validation of the Spondyloarthritis Research Consortium of Canada magnetic resonance imaging spinal inflammation index: Is it necessary to score the entire spine?, Arthritis Care & Research, 2007, 57, 3
  56. 56
    K Shanmuganandan, S Shankar, R Grover, CM Sridhar, MN Sreeram, J Raphael, A comparative evaluation of MRI, radionucleide bone scan and plain radiographs in Indian patients with spondyloarthropathy, Indian Journal of Rheumatology, 2006, 1, 2, 53

    CrossRef

  57. 57
    Martin Rudwaleit, Dominique Baeten, Ankylosing spondylitis and bowel disease, Best Practice & Research Clinical Rheumatology, 2006, 20, 3, 451

    CrossRef

  58. 58
    Jane Zochling, Jürgen Braun, Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis, Expert Opinion on Pharmacotherapy, 2006, 7, 7, 869

    CrossRef

  59. 59
    Cailin Henderson, John C Davis, Drug Insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis, Nature Clinical Practice Rheumatology, 2006, 2, 4, 211

    CrossRef

  60. 60
    Daniel Wendling, Eric Toussirot, Gérald Streit, Clément Prati, Imaging study scores for ankylosing spondylitis, Joint Bone Spine, 2006, 73, 6, 655

    CrossRef

  61. 61
    Daniel Wendling, Eric Toussirot, Gérald Streit, Clément Prati, Les scores d'imagerie de la spondylarthrite ankylosante, Revue du Rhumatisme, 2006, 73, 12, 1311

    CrossRef

  62. 62
    Xenofon Baraliakos, Robert Landewé, Juergen Braun, Magnetic resonance imaging in ankylosing spondylitis, Future Rheumatology, 2006, 1, 4, 423

    CrossRef

  63. 63
    Arthur Kavanaugh, Zuhre Tutuncu, Teresa Catalan-Sanchez, Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis, Current Opinion in Internal Medicine, 2006, 5, 5, 530

    CrossRef